IGC Pharma (IGC) Operating Leases (2020 - 2025)
IGC Pharma (IGC) posted quarterly Operating Leases of $2000.0 for Q4 2025, down 83.33% year-over-year from $12000.0 in Q4 2024, and down 60.0% quarter-over-quarter from $5000.0 in Q3 2025.
IGC Pharma (IGC) Operating Leases (2020 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Operating Leases for 6 consecutive years, with $2000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases fell 83.33% year-over-year to $2000.0; the TTM figure through Dec 2025 stood at $2000.0 (down 83.33% YoY), while the FY2025 annual figure was $10000.0, down 88.1% from the prior year.
- Operating Leases fell to $2000.0 in Q4 2025 per IGC's latest filing, from $5000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $433000.0 in Q2 2021 and bottomed at $2000.0 in Q4 2025.
- Historically, Operating Leases has averaged $182600.0 across 5 years, with a median of $162500.0 in 2023.
- Annual changes were most pronounced in 2021 — Operating Leases dropped 8.07% — and 2025, when it sank 89.86%.
- IGC Pharma's Operating Leases stood at $374000.0 in 2021, then sank by 35.56% to $241000.0 in 2022, then slumped by 52.28% to $115000.0 in 2023, then slumped by 89.57% to $12000.0 in 2024, then plunged by 83.33% to $2000.0 in 2025.
- Business Quant data shows IGC's Operating Leases at $2000.0 in Q4 2025, $5000.0 in Q3 2025, and $7000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Sep 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 179,000.00 |
| Mar 31, 2023 | 207,000.00 |
| Dec 31, 2022 | 241,000.00 |
| Sep 30, 2022 | 275,000.00 |
| Jun 30, 2022 | 308,000.00 |
| Mar 31, 2022 | 341,000.00 |
| Dec 31, 2021 | 374,000.00 |
| Sep 30, 2021 | 404,000.00 |
| Jun 30, 2021 | 433,000.00 |
| Mar 31, 2021 | 405,000.00 |